Literature DB >> 27723177

Peripheral intravenous catheters in situ for more than 96 h in adults: What factors affect removal?

Aiqun Zhu1, Ting Wang1, Shali Wen2.   

Abstract

Peripheral intravenous catheters (PIVC) are widely used in clinical nursing, but indwelling time remains a subject of debate. This study aimed to assess the risk factors for PIVC phlebitis in adults and provide a basis for indwelling time decisions. A total of 189 first-time PIVC patients in the emergency ward were assessed between May and October 2015. Data were retrieved for patient characteristics and PIVC assessment records. This study showed that over two-thirds (67.72%) of PIVCs were removed because of phlebitis, including oedema (37.57%), rubefaction (33.33%), pain (32.28%), slow infusion speed (13.23%) and accidental extrusion (2.12%). PIVC indwelling time in the planned removal group was higher than that obtained for the unplanned removal group: 152.42 (74.58) vs. 94.64 (50.15) h, P < 0.001. At indwelling times > 96 h, 28.57% (n = 54) of catheters caused phlebitis, although 23.28% (n = 44) showed no phlebitis. PIVC phlebitis was associated with treatment with compound amino acid infusion (OR: 2.624), site at the elbow joint (OR: 3.049), haemoglobin level (OR: 2.492), white cell count (OR: 2.196) and catheter size (OR: 1.837). Study findings suggest that PIVC might be used for longer durations based on nursing assessments and health education.
© 2016 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  indwelling time; nursing; peripheral intravenous catheter; phlebitis

Mesh:

Year:  2016        PMID: 27723177     DOI: 10.1111/ijn.12492

Source DB:  PubMed          Journal:  Int J Nurs Pract        ISSN: 1322-7114            Impact factor:   2.066


  1 in total

1.  Accidental removal of dialysis central venous catheter inserted for blood purification therapy: a single-center study.

Authors:  Shigeki Kojima; Yuhji Marui; Yugo Shibagaki; Tsutomu Sakurada
Journal:  Clin Exp Nephrol       Date:  2022-09-03       Impact factor: 2.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.